Congress Wealth Management LLC DE Trims Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Congress Wealth Management LLC DE lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 22.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,436 shares of the exchange traded fund’s stock after selling 6,008 shares during the quarter. Congress Wealth Management LLC DE’s holdings in SPDR S&P Biotech ETF were worth $1,841,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in XBI. Addison Advisors LLC raised its position in shares of SPDR S&P Biotech ETF by 27.4% in the fourth quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock valued at $48,000 after buying an additional 115 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in SPDR S&P Biotech ETF by 0.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock worth $2,373,000 after acquiring an additional 148 shares during the period. Invst LLC raised its holdings in SPDR S&P Biotech ETF by 6.0% in the 3rd quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock valued at $277,000 after acquiring an additional 160 shares during the last quarter. Beech Hill Advisors Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 2.5% during the 4th quarter. Beech Hill Advisors Inc. now owns 6,655 shares of the exchange traded fund’s stock worth $599,000 after purchasing an additional 162 shares during the period. Finally, Wealth Alliance boosted its holdings in shares of SPDR S&P Biotech ETF by 4.4% during the fourth quarter. Wealth Alliance now owns 4,083 shares of the exchange traded fund’s stock worth $368,000 after purchasing an additional 173 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $85.08 on Thursday. The company has a 50-day moving average of $89.52 and a 200-day moving average of $94.12. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company has a market cap of $5.52 billion, a P/E ratio of 11.47 and a beta of 0.99.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.